CSU has been a long-standing innovative partner with NIH/NIAID in assisting global mycobacterial research programs by offering services and biological reagents. Current programs include mycobacterial drug screening programs under the leadership of Dr. Anne Lenaerts and in vivo vaccine efficacy programs under the direction of Dr. Angelo Izzo.

Please contact the NIH/NIAID program officer (Dr. Tina Parker) if you are interested in requesting the services of these programs  [Or visit the website at http://www.niaid.nih.gov/labsandresources/resources/dmid/Pages/default.aspx].

In addition, under the leadership of Dr. Karen Dobos, CSU continues to generate specialized mycobacterial biological reagents; all materials are now available at no cost through the Biodefense and Emerging Infections Research Resources Repository (BEI Resources).